Gene · 57167
Papers3,058
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,058
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Colorectal adenocarcinoma with enteroblastic differentiation: a clinicopathological analysis of eight cases]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38556821 | PubTator, text mining | PubMed |
| Germ Cell Tumor Presenting as a Mesenteric Cyst: a Case Report and Literature Review. | Indian J Surg Oncol | 2024 | 38511034 | PubTator, text mining | PubMed |
| Alpha-fetoprotein producing endometrioid carcinoma arising in an adenomyoma of the uterus. | Med Mol Morphol | 2024 | 38466424 | PubTator, text mining | PubMed |
| Epithelioid Mesothelioma of Peritoneum Masquerading as Peritoneal Carcinomatosis. | Curr Med Imaging | 2024 | 38454767 | PubTator, text mining | PubMed |
| The long and winding road of reprogramming-induced rejuvenation. | Nat Commun | 2024 | 38431638 | PubTator, text mining | PubMed |
| Epigenetic-related transcriptional reprogramming elucidated by identification and validation of a novel reference gene combination for RT-qPCR studies in porcine oocytes of contrasting quality. | Mol Biol Rep | 2024 | 38411699 | PubTator, text mining | PubMed |
| Development of sulfonyl fluoride chemical probes to advance the discovery of cereblon modulators. | RSC Med Chem | 2024 | 38389883 | PubTator, text mining | PubMed |
| Retroperitoneal Sarcomatoid Yolk Sac Tumor in a Chemotherapy-Naive Patient With Testicular Postpubertal Type Teratoma: A Rare Case Report With Emphasis on Molecular Features. | Int J Surg Pathol | 2024 | 38377960 | PubTator, text mining | PubMed |
| Integrated analyses of the genetic and clinicopathological features of cholangiolocarcinoma: cholangiolocarcinoma may be characterized by mismatch-repair deficiency. | J Pathol | 2024 | 38362598 | PubTator, text mining | PubMed |
| High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasis. | Sci Rep | 2024 | 38355790 | PubTator, text mining | PubMed |
| SALL4 promotes cancer stem-like cell phenotype and radioresistance in oral squamous cell carcinomas via methyltransferase-like 3-mediated m6A modification. | Cell Death Dis | 2024 | 38355684 | PubTator, text mining | PubMed |
| Retraction: SALL4 as an Epithelial-Mesenchymal Transition and Drug Resistance Inducer through the Regulation of c-Myc in Endometrial Cancer. | PLoS One | 2024 | 38349941 | PubTator, text mining | PubMed |
| SALL4 deletion and kidney and cardiac defects associated with VACTERL association. | Pediatr Nephrol | 2024 | 38329589 | PubTator, text mining | PubMed |
| Enteroblastic cholangiocarcinoma: An uncommon, underrecognized subtype of bile duct cancer. | Hum Pathol | 2024 | 38301963 | PubTator, text mining | PubMed |
| Hepatocellular carcinoma metastatic to the pituitary gland without an identifiable primary lesion. | Radiol Case Rep | 2024 | 38292788 | PubTator, text mining | PubMed |
| Prolonged generalized osteomalacia associated with a sinonasal cavity phosphaturic mesenchymal tumor: A case report. | Clin Case Rep | 2024 | 38292224 | PubTator, text mining | PubMed |
| [Cytopathological characteristics of SMARCA4-deficient thoracic undifferentiated tumors in serous effusion]. | Zhonghua Bing Li Xue Za Zhi | 2024 | 38281781 | PubTator, text mining | PubMed |
| Pyroptosis-Related Gene Signature Predicts Prognosis and Response to Immunotherapy and Medication in Pediatric and Young Adult Osteosarcoma Patients. | J Inflamm Res | 2024 | 38269108 | PubTator, text mining | PubMed |
| ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target? | Biomedicines | 2024 | 38255216 | PubTator, text mining | PubMed |
| Aberrant trophoblastic differentiation in human cancer: An emerging novel therapeutic target (Review). | Oncol Rep | 2024 | 38240107 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57167/papers?page=13